NCT06896695 A Financial Intervention (Financial Compass) to Identify and Address Financial Hardship Among Head and Neck Cancer Patients, Financial Compass Trial
| NCT ID | NCT06896695 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Roswell Park Cancer Institute |
| Condition | Head and Neck Carcinoma |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-09-23 |
| Primary Completion | 2027-02-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2025-09-23 with a primary completion date of 2027-02-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This clinical trial compares the effect a financial intervention, called Financial Compass, to usual care in identifying and addressing financial hardship in patients with head and neck cancer. Previous research has shown that head and neck cancer patients experiencing financial hardship have decreased overall and cancer specific survival. Using a financial intervention, Financial Compass, may be more effective than usual care in identifying and addressing financial hardship in patients with head and neck cancer.
Eligibility Criteria
Inclusion Criteria: * They have been diagnosed with head and neck cancer * Screen positive for financial hardship on the validated Comprehensive Score for Financial Toxicity (COST) measure * Are able to participate in English or Spanish Exclusion Criteria: * Adults unable to complete the process of informed consent * Adults whose primary language is not English or Spanish * Individuals who are not yet adults (i.e., infants, children, teenagers) * Unwilling or unable to follow protocol requirements
Contact & Investigator
Elizabeth Bouchard
PRINCIPAL INVESTIGATOR
Roswell Park Cancer Institute
Frequently Asked Questions
Who can join the NCT06896695 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Head and Neck Carcinoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06896695 currently recruiting?
Yes, NCT06896695 is actively recruiting participants. Visit ClinicalTrials.gov or contact Roswell Park Cancer Institute to inquire about joining.
Where is the NCT06896695 trial being conducted?
This trial is being conducted at Buffalo, United States.
Who is sponsoring the NCT06896695 clinical trial?
NCT06896695 is sponsored by Roswell Park Cancer Institute. The principal investigator is Elizabeth Bouchard at Roswell Park Cancer Institute. The trial plans to enroll 50 participants.